A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCI

Objectives: High thrombus burden during Primary Percutaneous Coronary Intervention begets poor outcomes; there are several lacunas in the management of those patients.- The purpose of this study is to analyse the long-term outcomes of patients undergoing primary percutaneous coronary intervention wi...

Full description

Saved in:
Bibliographic Details
Main Authors: Venkata RS. Subrahmanya Sarma, K. Gopalakrishna, K. Purnachandra Rao, G. Somasekahr, P.S.S. Chowdary, P. Raghuram, B. Dasarath, Manohar Reddy, Ramkishore, Raji Veeramachineni, Y. Sasidhar, M. Prasad
Format: Article
Language:English
Published: Elsevier 2025-05-01
Series:Indian Heart Journal
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0019483225000094
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849689232076963840
author Venkata RS. Subrahmanya Sarma
K. Gopalakrishna
K. Purnachandra Rao
G. Somasekahr
P.S.S. Chowdary
P. Raghuram
B. Dasarath
Manohar Reddy
Ramkishore
Raji Veeramachineni
Y. Sasidhar
M. Prasad
author_facet Venkata RS. Subrahmanya Sarma
K. Gopalakrishna
K. Purnachandra Rao
G. Somasekahr
P.S.S. Chowdary
P. Raghuram
B. Dasarath
Manohar Reddy
Ramkishore
Raji Veeramachineni
Y. Sasidhar
M. Prasad
author_sort Venkata RS. Subrahmanya Sarma
collection DOAJ
description Objectives: High thrombus burden during Primary Percutaneous Coronary Intervention begets poor outcomes; there are several lacunas in the management of those patients.- The purpose of this study is to analyse the long-term outcomes of patients undergoing primary percutaneous coronary intervention with high thrombus burden, treated with intracoronary thrombolysis as an adjunctive therapy. Methods: In this prospective observational study, 108 consecutive primary percutaneous coronary intervention patients with high thrombus burden were stratified into two groups basing on whether they received intracoronary thrombolytic agent before stent implantation. The primary outcome is Net Adverse Clinical Events. Secondary outcomes include Major Adverse Cardiac Events, and all other individual components of the Net Adverse Clinical Events when analysed separately. Results: The primary outcome events occurred in 21 patients (26 %) in the Primary stent group (n = 80), whereas it occurred in 2 patients (6 %) in the primary intra-coronary thrombolysis group (n = 28), this study shows that there is no difference in primary endpoints in both groups (26 % Vs 7 %, p-value – .042, Hazard ratio - 2.56; 95 % CI - .76–8.57), however Kaplan–Meier event-free survival curves show that both the curves are well separated apart even at the end of the one year of follow – up. Conclusion: There is no difference in the primary outcome events in both groups, however there was a consistent increase in events in the primary stent group over the one-year follow-up period. These findings suggest the need for a larger randomized clinical trial to confirm and further elucidate these results.
format Article
id doaj-art-9c4977d7d9904b0ab1a7bf208b0b6be1
institution DOAJ
issn 0019-4832
language English
publishDate 2025-05-01
publisher Elsevier
record_format Article
series Indian Heart Journal
spelling doaj-art-9c4977d7d9904b0ab1a7bf208b0b6be12025-08-20T03:21:42ZengElsevierIndian Heart Journal0019-48322025-05-0177319319810.1016/j.ihj.2025.01.008A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCIVenkata RS. Subrahmanya Sarma0K. Gopalakrishna1K. Purnachandra Rao2G. Somasekahr3P.S.S. Chowdary4P. Raghuram5B. Dasarath6Manohar Reddy7 Ramkishore8Raji Veeramachineni9Y. Sasidhar10M. Prasad11Corresponding author.; Cardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaCardiology Department, Aayush Hospitals, Vijayawada, Andhra Pradesh, IndiaObjectives: High thrombus burden during Primary Percutaneous Coronary Intervention begets poor outcomes; there are several lacunas in the management of those patients.- The purpose of this study is to analyse the long-term outcomes of patients undergoing primary percutaneous coronary intervention with high thrombus burden, treated with intracoronary thrombolysis as an adjunctive therapy. Methods: In this prospective observational study, 108 consecutive primary percutaneous coronary intervention patients with high thrombus burden were stratified into two groups basing on whether they received intracoronary thrombolytic agent before stent implantation. The primary outcome is Net Adverse Clinical Events. Secondary outcomes include Major Adverse Cardiac Events, and all other individual components of the Net Adverse Clinical Events when analysed separately. Results: The primary outcome events occurred in 21 patients (26 %) in the Primary stent group (n = 80), whereas it occurred in 2 patients (6 %) in the primary intra-coronary thrombolysis group (n = 28), this study shows that there is no difference in primary endpoints in both groups (26 % Vs 7 %, p-value – .042, Hazard ratio - 2.56; 95 % CI - .76–8.57), however Kaplan–Meier event-free survival curves show that both the curves are well separated apart even at the end of the one year of follow – up. Conclusion: There is no difference in the primary outcome events in both groups, however there was a consistent increase in events in the primary stent group over the one-year follow-up period. These findings suggest the need for a larger randomized clinical trial to confirm and further elucidate these results.http://www.sciencedirect.com/science/article/pii/S0019483225000094PPCIPrimary percutaneous coronary agentsSTEMIST-Segment elevation myocardial infarctionNACENet adverse clinical events
spellingShingle Venkata RS. Subrahmanya Sarma
K. Gopalakrishna
K. Purnachandra Rao
G. Somasekahr
P.S.S. Chowdary
P. Raghuram
B. Dasarath
Manohar Reddy
Ramkishore
Raji Veeramachineni
Y. Sasidhar
M. Prasad
A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCI
Indian Heart Journal
PPCI
Primary percutaneous coronary agents
STEMI
ST-Segment elevation myocardial infarction
NACE
Net adverse clinical events
title A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCI
title_full A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCI
title_fullStr A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCI
title_full_unstemmed A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCI
title_short A study of intracoronary thrombolytic agents in high thrombus burden lesions during primary PCI
title_sort study of intracoronary thrombolytic agents in high thrombus burden lesions during primary pci
topic PPCI
Primary percutaneous coronary agents
STEMI
ST-Segment elevation myocardial infarction
NACE
Net adverse clinical events
url http://www.sciencedirect.com/science/article/pii/S0019483225000094
work_keys_str_mv AT venkatarssubrahmanyasarma astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT kgopalakrishna astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT kpurnachandrarao astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT gsomasekahr astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT psschowdary astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT praghuram astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT bdasarath astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT manoharreddy astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT ramkishore astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT rajiveeramachineni astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT ysasidhar astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT mprasad astudyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT venkatarssubrahmanyasarma studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT kgopalakrishna studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT kpurnachandrarao studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT gsomasekahr studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT psschowdary studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT praghuram studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT bdasarath studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT manoharreddy studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT ramkishore studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT rajiveeramachineni studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT ysasidhar studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci
AT mprasad studyofintracoronarythrombolyticagentsinhighthrombusburdenlesionsduringprimarypci